ES549116A0 - Procedimiento para obtencion de derivados de flavolignano - Google Patents

Procedimiento para obtencion de derivados de flavolignano

Info

Publication number
ES549116A0
ES549116A0 ES549116A ES549116A ES549116A0 ES 549116 A0 ES549116 A0 ES 549116A0 ES 549116 A ES549116 A ES 549116A ES 549116 A ES549116 A ES 549116A ES 549116 A0 ES549116 A0 ES 549116A0
Authority
ES
Spain
Prior art keywords
flavolignano
procedure
obtaining derivatives
derivatives
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549116A
Other languages
English (en)
Other versions
ES8609311A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Dr Madaus GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co filed Critical Dr Madaus GmbH and Co
Publication of ES8609311A1 publication Critical patent/ES8609311A1/es
Publication of ES549116A0 publication Critical patent/ES549116A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
ES549116A 1984-11-22 1985-11-21 Procedimiento para obtencion de derivados de flavolignano Expired ES8609311A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
ES8609311A1 ES8609311A1 (es) 1986-09-01
ES549116A0 true ES549116A0 (es) 1986-09-01

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549116A Expired ES8609311A1 (es) 1984-11-22 1985-11-21 Procedimiento para obtencion de derivados de flavolignano

Country Status (29)

Country Link
JP (1) JPS61143377A (es)
KR (1) KR870001020B1 (es)
AR (1) AR240931A1 (es)
AT (1) AT393268B (es)
BE (1) BE903693A (es)
CA (1) CA1337124C (es)
CH (1) CH659473A5 (es)
CS (1) CS273610B2 (es)
DD (1) DD259191A1 (es)
DE (1) DE3442639A1 (es)
DK (1) DK164865C (es)
EG (1) EG19424A (es)
ES (1) ES8609311A1 (es)
FI (1) FI84064C (es)
FR (1) FR2573427B1 (es)
GB (1) GB2167414B (es)
HU (1) HU195503B (es)
IE (1) IE58791B1 (es)
IT (1) IT1190426B (es)
LU (1) LU86163A1 (es)
MX (1) MX168415B (es)
NL (1) NL192387C (es)
NO (1) NO160205C (es)
PL (1) PL146890B1 (es)
PT (1) PT81532B (es)
SE (1) SE465676B (es)
SU (1) SU1436875A3 (es)
YU (1) YU43689B (es)
ZA (1) ZA858951B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
AU2006222556B2 (en) * 2005-03-11 2011-09-29 Armaron Bio Pty Ltd Flavonoid compounds and uses thereof
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
PT2219642E (pt) * 2007-11-15 2011-10-18 Madaus Gmbh Componente de silibinina para o tratamento de hepatite
JP5841048B2 (ja) 2009-05-14 2016-01-06 エウロメッド・エセ・ア ウイルス性肝炎の治療のための非晶質シリビニン
AU2013286721B2 (en) 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
CS273610B2 (en) 1991-03-12
FI84064B (fi) 1991-06-28
DK537785A (da) 1986-05-23
ES8609311A1 (es) 1986-09-01
FR2573427B1 (fr) 1989-03-10
NL192387B (nl) 1997-03-03
PL256374A1 (en) 1986-12-02
JPH0432073B2 (es) 1992-05-28
PT81532B (pt) 1987-11-11
ATA337185A (de) 1991-02-15
IT8522932A0 (it) 1985-11-21
EG19424A (en) 1995-02-28
HU195503B (en) 1988-05-30
MX168415B (es) 1993-05-24
CS837885A2 (en) 1990-08-14
AR240931A1 (es) 1991-03-27
NO160205C (no) 1989-03-22
KR870001020B1 (ko) 1987-05-23
IE58791B1 (en) 1993-11-17
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
AT393268B (de) 1991-09-25
CH659473A5 (de) 1987-01-30
FI854535A7 (fi) 1986-05-23
PT81532A (de) 1985-12-01
ZA858951B (en) 1986-08-27
FR2573427A1 (fr) 1986-05-23
DE3442639A1 (de) 1986-05-22
CA1337124C (en) 1995-09-26
NO160205B (no) 1988-12-12
DD259191A1 (de) 1988-08-17
LU86163A1 (de) 1986-03-24
HUT40114A (en) 1986-11-28
FI84064C (fi) 1991-10-10
NO854655L (no) 1986-05-23
IT1190426B (it) 1988-02-16
FI854535A0 (fi) 1985-11-18
GB2167414B (en) 1989-01-11
GB2167414A (en) 1986-05-29
YU178685A (en) 1988-02-29
DE3442639C2 (es) 1989-08-10
DK164865B (da) 1992-08-31
IE852808L (en) 1986-05-22
AR240931A2 (es) 1991-03-27
SE8505487D0 (sv) 1985-11-20
DK164865C (da) 1993-01-18
NL192387C (nl) 1997-07-04
BE903693A (fr) 1986-05-22
DK537785D0 (da) 1985-11-21
KR860004056A (ko) 1986-06-16
JPS61143377A (ja) 1986-07-01
GB8528226D0 (en) 1985-12-18
SU1436875A3 (ru) 1988-11-07
NL8503171A (nl) 1986-06-16

Similar Documents

Publication Publication Date Title
ES548798A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo
ES555047A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropilcarbinol sustituido
ES539781A0 (es) Procedimiento para la obtencion de 5-amino-fenil-pirazoles sustituidos
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
ES544341A0 (es) Procedimiento para la obtencion de heteroariloxiacetamidas
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES546493A0 (es) Procedimiento para la obtencion de derivados de flavanona
ES556157A0 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES549116A0 (es) Procedimiento para obtencion de derivados de flavolignano
ES554371A0 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES543896A0 (es) Procedimiento para la obtencion de derivados triacinicos de colorantes diazoicos
ES555278A0 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
ES546681A0 (es) Procedimiento para la obtencion de fenilsulfonilazoles sus- tituidos
ES554606A0 (es) Procedimiento para la obtencion de piridiletil-dihidropiridinas
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES536664A0 (es) Procedimiento para la obtencion de derivados de azolil-tetrahidro-furan-2-iliden-metano
AR242387A1 (es) Procedimiento para la preparacion de nuevos derivados de apovincaminol
ES547487A0 (es) Procedimiento para la obtencion de derivados de la pirazolo-na
ES540412A0 (es) Procedimiento para la obtencion de oxiranos sustituidos
ES546923A0 (es) Procedimiento para la obtencion de derivados de salicilamida
ES545451A0 (es) Procedimiento para la fabricacion de derivados de pirrolidi-na
ES532084A0 (es) Procedimiento para la obtencion de derivados de isopropilamino-2-propanol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102